STRS OHIO - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$636,000
-0.2%
185,000
-26.9%
0.00%0.0%
Q4 2020$637,000
+39.4%
253,000
+16.6%
0.00%0.0%
Q3 2020$457,000
-2.4%
217,000
+3.8%
0.00%0.0%
Q2 2020$468,000
+15.0%
209,000
+29.9%
0.00%0.0%
Q1 2020$407,000
-3.8%
160,9000.0%0.00%0.0%
Q4 2019$423,000
-63.5%
160,900
-50.0%
0.00%
-33.3%
Q3 2019$1,158,000
+128.4%
321,800
+113.5%
0.00%
+50.0%
Q2 2019$507,000
-9.5%
150,700
-26.6%
0.00%
-33.3%
Q1 2019$560,000
+8.3%
205,400
+10.4%
0.00%0.0%
Q4 2018$517,000
-25.8%
186,100
+9.9%
0.00%0.0%
Q3 2018$697,000
+0.6%
169,300
+26.7%
0.00%0.0%
Q2 2018$693,000
+20.5%
133,600
+27.1%
0.00%0.0%
Q1 2018$575,000
-11.8%
105,100
+31.4%
0.00%0.0%
Q4 2017$652,000
-7.0%
80,000
+19.4%
0.00%0.0%
Q3 2017$701,000
+1.6%
67,000
+7.2%
0.00%0.0%
Q2 2017$690,000
+6.6%
62,500
-19.1%
0.00%0.0%
Q1 2017$647,000
-3.9%
77,300
-20.3%
0.00%0.0%
Q4 2016$673,000
+11.8%
97,000
-18.1%
0.00%0.0%
Q3 2016$602,000
-7.8%
118,431
+8.3%
0.00%0.0%
Q2 2016$653,000
+30.3%
109,400
-35.6%
0.00%
+50.0%
Q1 2015$501,000
-26.4%
169,847
+10.7%
0.00%
-33.3%
Q4 2014$681,000
-45.0%
153,400
-36.2%
0.00%0.0%
Q3 2014$1,238,000
+88.7%
240,400
+92.5%
0.00%0.0%
Q2 2014$656,000124,9000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2016
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders